Engineering cell signaling using tunable CRISPR-Cpf1-based transcription factors.

Yuchen Liu1, Jinghong Han1,2, Zhicong Chen1

  • 1Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518039, China.

Nature Communications
|December 14, 2017
PubMed
Summary

Researchers repurposed the catalytically dead Cpf1 endonuclease (dAsCpf1) system for gene regulation in human cells. This engineered system enables programmable, ligand-controlled gene activation or repression, creating artificial signaling pathways.